<< Back

American Pacific Reports Fiscal 2010 First Quarter Results; Reaffirms Fiscal 2010 Guidance

LAS VEGAS, Feb 10, 2010 /PRNewswire via COMTEX/ -- American Pacific Corporation (Nasdaq: APFC) today reported financial results for its fiscal 2010 first quarter ended December 31, 2009.

We provide non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data.

FINANCIAL SUMMARY

Quarter Ended December 31, 2009 Compared to Quarter Ended December 31, 2008

  • Revenues decreased $11.5 million, or 25%, to $34.1 million from $45.6 million.
  • Operating income was $0.1 million compared to operating income of $3.4 million.
  • Adjusted EBITDA was $4.5 million compared to $7.6 million.
  • Net loss was $1.4 million compared to net income of $0.5 million.
  • Diluted loss per share was $0.19 compared to diluted earnings per share of $0.06.

CONSOLIDATED RESULTS OF OPERATIONS

Revenues -For our first quarter of the fiscal year ending September 30, 2010 ("Fiscal 2010"), revenues decreased 25% to $34.1 million as compared to the first quarter of the fiscal year ended September 30, 2009 ("Fiscal 2009"), reflecting an increase of 45% for Aerospace Equipment segment revenues, offset by decreases of 53% and 26% in Fine Chemicals segment and Specialty Chemicals segment revenues, respectively.

See further discussion under Segment Highlights.

Cost of Revenuesand Gross Margins - For our Fiscal 2010 first quarter, cost of revenues was $21.6 million compared to $30.9 million for the prior fiscal year first quarter. The consolidated gross margin percentage was 37% and 32% for our Fiscal 2010 and Fiscal 2009 first quarters, respectively.

One of the most significant factors that affects, and should continue to affect, the comparison of our consolidated gross margins from period to period is the change in revenue mix between our segments. The revenue contribution by each of our segments is indicated in the following table.

                                               Three Months Ended

                                                  December 31,

                                                2009        2008

                                                ----        ----

    Fine Chemicals                               28%         45%

    Specialty Chemicals                          38%         38%

    Aerospace Equipment                          24%         13%

    Other Businesses                             10%          4%

                                                ---         ---

      Total Revenues                            100%        100%

                                                ===         ===

 

In addition, consolidated gross margins for our Fiscal 2010 first quarter reflect:

  • An increase in Fine Chemicals segment gross margin percentage primarily because manufacturing inefficiencies in the first quarter of Fiscal 2009 did not reoccur in the first quarter of Fiscal 2010.
  • An increase in Specialty Chemicals segment gross margin percentage due primarily to lower costs for perchlorates sold in the quarter.
  • A decline in Aerospace Equipment segment gross margin percentage due to increases in the estimated costs to complete certain of its systems contracts.

See further discussion under Segment Highlights.

Operating Expenses - For our Fiscal 2010 first quarter, operating expenses increased $1.0 million to $12.3 million from $11.3 million for the prior fiscal year first quarter. The most significant components of the net increase include:

  • A decrease in Specialty Chemicals segment operating expenses primarily due to a decrease of $0.2 million in employee related costs.
  • An increase in Aerospace Equipment segment operating expenses of $0.6 million primarily due to additional management and organization structure which was added to support the segment's European growth strategy.
  • An increase in corporate expenses, the largest component of which is an increase of $0.2 million in non-cash, stock-based compensation.

SEGMENT HIGHLIGHTS

Fine Chemicals Segment

Our Fine Chemicals segment reflects the operating results of our wholly-owned subsidiary Ampac Fine Chemicals LLC ("AFC").

Quarter Ended December 31, 2009 Compared to Quarter Ended December 31, 2008

  • Revenues were $9.5 million compared to revenuesof $20.4 million.
  • Operating loss was $0.7 million compared to an operating loss of $1.0 million.
  • Segment EBITDA was $2.6 million, or 27% of segment revenues, compared to Segment EBITDA of $2.2 million, or 11% of segment revenues.

The decrease in Fine Chemicals segment revenues for the Fiscal 2010 first quarter compared to the prior fiscal year first quarter is primarily due to the expected timing of customer orders, and the resulting revenues, between our fiscal year quarterly periods. The percentage of expected annual Fiscal 2010 Fine Chemicals segment revenues that occurred in our Fiscal 2010 first quarter is substantially less than the percentage of annual Fiscal 2009 revenues that occurred in our Fiscal 2009 first quarter. As a secondary factor, we expect Fiscal 2010 annual revenues to decline as compared to Fiscal 2009 due to reduced orders for core products. A portion of this decline occurred in the Fiscal 2010 first quarter.

Our Fine Chemicals segment reported an operating loss of $0.7 million for the Fiscal 2010 first quarter compared to an operating loss of $1.0 million for the prior fiscal year first quarter. Despite the greater than 50% decline in revenues, the operating loss was reduced. The gross margin percentage for the Fiscal 2010 first quarter improved seventeen points compared to the prior fiscal year first quarter. The primary reason for the improvement is that manufacturing inefficiencies that affected the first quarter of Fiscal 2009 did not reoccur in the Fiscal 2010 first quarter. Fine Chemicals segment operating expenses were consistent between the Fiscal 2010 and Fiscal 2009 first quarters.

Specialty Chemicals Segment

Our Specialty Chemicals segment revenues include the operating results from our perchlorate, sodium azide and Halotron product lines, with perchlorates comprising 86% and 92% of Specialty Chemicals segment revenues in Fiscal 2010 and Fiscal 2009 first quarters, respectively.

Quarter Ended December 31, 2009 Compared to Quarter Ended December 31, 2008

  • Revenues decreased to $12.8 million from $17.4 million.
  • Operating income was $5.8 million, or 46% of segment revenues, compared to $7.6 million, or 44% of segment revenues.
  • Segment EBITDA was $6.0 million, or 47% of segment revenues, compared to $7.9 million, or 46% of segment revenues.

The variances in Specialty Chemicals segment revenues reflect the following factors:

  • A 46% decrease in perchlorate volume offset by a 27% increase in the related average price per pound.
  • Sodium azide revenues increased $0.7 million for the Fiscal 2010 first quarter, reflecting increased sales outside the U.S.
  • Halotron revenues were consistent between the first quarter periods.

The decrease in volume for the Fiscal 2010 first quarter is consistent with our expectation that total perchlorate volume for Fiscal 2010 is anticipated to decline by approximately 50% compared to the prior fiscal year. The increase in average price per pound reflects price increases from our contractual Grade I ammonium perchlorate ("AP") price-volume matrix offset by effects of increases in non-Grade I AP revenues. Space related programs accounted for the most significant component of Grade I AP revenues for both the Fiscal 2010 and Fiscal 2009 first quarter. For the Fiscal 2010 first quarter, the greatest contributor to revenue was the Ares program. For the Fiscal 2009 first quarter, the greatest contributor to segment revenue was product for the Space Shuttle Reusable Solid Rocket Motor ("RSRM") program.

Specialty Chemicals segment operating income was 46% and 44% of segment revenues, for the Fiscal 2010 and Fiscal 2009 first quarters, respectively. Specialty Chemicals segment gross margin percentage improved four points for the Fiscal 2010 first quarter. For Fiscal 2010, we anticipate that both the price and manufacturing cost of AP per pound will increase because of the expected lower volume. However, in the Fiscal 2010 first quarter, some of the perchlorates sold were manufactured in the prior year at a lower unit cost. As such, when this prior year inventory was sold in the first quarter of Fiscal 2010, gross margins benefited.

Operating expenses decreased for the Fiscal 2010 first quarter primarily due to a decrease of $0.2 million in employee related costs.

Aerospace Equipment Segment

Our Aerospace Equipment segment reflects the operating results of our wholly-owned subsidiary Ampac-ISP Corp. and its wholly-owned subsidiaries (collectively, "AMPAC ISP").

Quarter Ended December 31, 2009 Compared to Quarter Ended December 31, 2008

  • Revenues increased 45% to $8.3 million from $5.8 million.
  • Operating loss was $0.4 million compared to operating income of $0.4 million.
  • Segment EBITDA was $0.1 million compared to $0.7 million.

For the Fiscal 2010 first quarter, Aerospace Equipment segment revenues increased $2.5 million representing growth from both the U.S. and European operations of this segment. Growth for AMPAC ISP's U.S. operation was primarily due to an increase in revenues from in-space propulsion engines. AMPAC ISP's European operations reported increases in revenues for both in-space propulsion engines and aerospace structures.

Aerospace Equipment segment operating loss for the Fiscal 2010 first quarter was $0.4 million compared to operating income of $0.4 million for the prior fiscal year first quarter. Aerospace Equipment segment gross margin percentage declined thirteen points in the Fiscal 2010 first quarter compared to the prior fiscal year first quarter. The decline in gross margin is attributed to increases in the estimated costs to complete certain systems contracts. Aerospace Equipment segment operating expenses increased $0.6 million primarily as a result of additional management and organization structure which was added to support the segment's European growth strategy.

CAPITAL AND LIQUIDITY HIGHLIGHTS

Liquidity - As of December 31, 2009, we had cash balances of $38.6 million and no cash borrowings against our $20.0 million revolving credit line. In addition, we were in compliance with the various covenants contained in our credit agreements.

Operating Cash Flows - Operating activities provided cash of $18.1 million for the Fiscal 2010 first quarter compared to $7.0 million for the prior fiscal year first quarter, resulting in an increase of $11.1 million.

Significant components of the change in cash flow from operating activities include:

  • A decrease in cash provided by Adjusted EBITDA of $3.1 million.
  • An increase in cash provided by working capital accounts of $13.7 million, excluding the effects of interest and income taxes.
  • An increase in cash taxes refunded of $0.8 million.
  • An increase in cash used for environmental remediation of $0.3 million.

The increase in cash provided by working capital accounts for the Fiscal 2010 first quarter is primarily due to a decrease in accounts receivable balances for our Specialty Chemicals segment from its higher balance at September 30, 2009, which was substantially collected in October 2009.

We consider these working capital changes to be routine and within the normal production cycle of our products. The production of most fine chemical products requires a length of time that exceeds one quarter. In addition, the timing of Aerospace Equipment segment revenues recognized under the percentage-of-completion method differs from the timing of the related billings to customers. Therefore, in any given quarter, accounts receivable, work-in-progress inventory or deferred revenues can increase or decrease significantly. We expect that our working capital may vary normally by as much as $10.0 million from quarter to quarter.

Investing Cash Flows - Capital expenditures decreased by $0.7 million in the Fiscal 2010 first quarter compared to the prior fiscal year first quarter due to the timing of expenditures. Capital expenditures in both periods are primarily maintenance capital related.

OUTLOOK

We are reaffirming our guidance for Fiscal 2010. We expect consolidated revenues of at least $190.0 million, Adjusted EBITDA of at least $30.0 million and net income of at least $1.0 million. Our Fiscal 2010 guidance for Adjusted EBITDA is computed by adding estimated amounts for depreciation and amortization of $16.0 million, interest expense of $11.0 million, share-based compensation expense of $1.0 million and income taxes of $1.0 million to estimated net income of $1.0 million. We are anticipating our capital expenditures, which do not include environmental remediation spending, for Fiscal 2010 to range from approximately $10.0 million to approximately $14.0 million.

Change in Accounting Standard. Effective October 1, 2009, we adopted a revised accounting standard that requires us to expense acquisition related costs, such as legal fees, when incurred. Under the previous accounting standard, these costs were included in the total cost of an acquisition and capitalized. Our Fiscal 2010 guidance for Adjusted EBITDA includes no amounts for acquisition related costs. Accordingly, should we pursue an acquisition, direct costs associated with that action would be incremental to our guidance.

INVESTOR TELECONFERENCE

We invite you to participate in a teleconference with our executive management covering our Fiscal 2010 first quarter financial results. The investor teleconference will be held Wednesday, February 10, 2010 at 1:30 p.m., Pacific Standard Time. The teleconference will include a presentation by management followed by a question and answer session. The teleconference can be accessed by dialing 866-770-7120 between 1:15 and 1:30 p.m., Pacific Standard Time. Please reference passcode #21270549. As is our customary practice, a live webcast of the teleconference is being provided by Thomson Reuters. A link to the webcast and the earnings release is available at our website at www.apfc.com, and will be available for replay until a few days before our next quarterly investor teleconference.

RISK FACTORS/FORWARD-LOOKING STATEMENTS

The unaudited financial results included in this release are preliminary. Statements contained in this earnings release that are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation the statement regarding one of the significant factors that will affect our consolidated gross margins in the future, the statement regarding anticipated Fiscal 2010 Fine Chemicals segment revenues, the statement regarding the anticipated price, manufacturing cost and total volume of perchlorate products to be sold for Fiscal 2010, statements regarding our working capital changes and future variations, and statements in the "Outlook" section of this earnings release. Words such as "anticipate", "estimate", "expect", "should", "could", "may", "can" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our expectations will be achieved. Actual results may differ materially from future results or outcomes expressed or implied by forward-looking statements set forth in the release due to risks, uncertainties and other important factors inherent in our business. Factors that might cause actual results to differ include, but are not limited to, the following:

  • We depend on a limited number of customers for most of our sales in our Specialty Chemicals, Aerospace Equipment and Fine Chemicals segments and the loss of one or more of these customers could have a material adverse effect on our financial position, results of operations and cash flows.
  • The inherent limitations of our fixed-price or similar contracts may impact our profitability.
  • The numerous and often complex laws and regulations and regulatory oversight to which our operations and properties are subject, the cost of compliance, and the effect of any failure to comply could reduce our profitability and liquidity.
  • A significant portion of our business depends on contracts with the government or its prime contractors or subcontractors and these contracts are impacted by governmental priorities and are subject to potential fluctuations in funding or early termination, including for convenience, any of which could have a material adverse effect on our operating results, financial condition or cash flows.
  • We may be subject to potentially material costs and liabilities in connection with environmental or health matters.
  • Although we have established an environmental reserve for remediation activities in Henderson, Nevada, given the many uncertainties involved in assessing environmental liabilities, our environmental-related risks may from time to time exceed any related reserves.
  • For each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments, most production is conducted in a single facility and any significant disruption or delay at a particular facility could have a material adverse effect on our business, financial position and results of operations.
  • The release or explosion of dangerous materials used in our business could disrupt our operations and cause us to incur additional costs and liabilities.
  • Disruptions in the supply of key raw materials and difficulties in the supplier qualification process, as well as increases in prices of raw materials, could adversely impact our operations.
  • Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments may be unable to comply with customer specifications and manufacturing instructions or may experience delays or other problems with existing or new products, which could result in increased costs, losses of sales and potential breach of customer contracts.
  • Successful commercialization of pharmaceutical products and product line extensions is very difficult and subject to many uncertainties. If a customer is not able to successfully commercialize its products for which AFC produces compounds or if a product is subsequently recalled, then the operating results of AFC may be negatively impacted.
  • A strike or other work stoppage, or the inability to renew collective bargaining agreements on favorable terms, could have a material adverse effect on the cost structure and operational capabilities of AFC.
  • The pharmaceutical fine chemicals industry is a capital-intensive industry and if AFC does not have sufficient financial resources to finance the necessary capital expenditures, its business and results of operations may be harmed.
  • We may be subject to potential liability claims for our products or services that could affect our earnings and financial condition and harm our reputation.
  • Technology innovations in the markets that we serve may create alternatives to our products and result in reduced sales.
  • We are subject to strong competition in certain industries in which we participate and therefore may not be able to compete successfully.
  • Due to the nature of our business, our sales levels may fluctuate causing our quarterly operating results to fluctuate.
  • The inherent volatility of the chemical industry affects our capacity utilization and causes fluctuations in our results of operations.
  • A loss of key personnel or highly skilled employees, or the inability to attract and retain such personnel, could disrupt our operations or impede our growth.
  • We may continue to expand our operations in part through acquisitions, which could divert management's attention and expose us to unanticipated liabilities and costs. We may experience difficulties integrating the acquired operations, and we may incur costs relating to acquisitions that are never consummated.
  • We have a substantial amount of debt, and the cost of servicing that debt could adversely affect our ability to take actions, our liquidity or our financial condition.
  • If we are unable to generate sufficient cash flow to service our debt and fund our operating costs, our liquidity may be adversely affected.
  • Significantchanges in discount rates, rates of return on pension assets, mortality tables and other factors could affect our estimates of pension obligations, which in turn could affect future funding requirements and related costs and impact our future earnings.
  • Our shareholder rights plan, Restated Certificate of Incorporation, as amended, and Amended and Restated By-laws discourage unsolicited takeover proposals and could prevent stockholders from realizing a premium on their common stock.
  • Our proprietary and intellectual property rights may be violated, compromised, circumvented or invalidated, which could damage our operations.
  • Our common stock price may fluctuate substantially, and a stockholder's investment could decline in value.

Readers of this earnings release are referred to our Annual Report on Form 10-K for Fiscal 2009 and our other filings with the Securities and Exchange Commission for further discussion of these and other factors that could affect our future results. The forward-looking statements contained in this earnings release are made as of the date hereof and we assume no obligation to update for actual results or to update the reasons why actual results could differ materially from those projected in the forward-looking statements, except as required by law. In addition, the operating results for the quarter ended December 31, 2009 are not necessarily indicative of the results that will be achieved for future periods.

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at http://www.apfc.com/.

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Statements of Operations

    (Unaudited, Dollars in Thousands, Except per Share Amounts)

    -----------------------------------------------------------

                                                    Three Months Ended

                                                       December 31,

                                                     2009         2008

                                                     ----         ----

    Revenues                                       $34,064      $45,629

    Cost of Revenues                                21,618       30,895

                                                    ------       ------

      Gross Profit                                  12,446       14,734

    Operating Expenses                              12,307       11,309

                                                    ------       ------

      Operating Income                                 139        3,425

    Interest and Other Income (Expense), Net            (8)          61

    Interest Expense                                 2,691        2,694

                                                     -----        -----

      Income (Loss) before Income Tax               (2,560)         792

    Income Tax Expense (Benefit)                    (1,120)         335

                                                    ------          ---

      Net Income (Loss)                            $(1,440)        $457

                                                   =======         ====

 

    Earnings (Loss) per Share:

      Basic                                         $(0.19)       $0.06

      Diluted                                       $(0.19)       $0.06

    Weighted Average Shares Outstanding:

      Basic                                      7,487,000    7,480,000

      Diluted                                    7,487,000    7,573,000

 

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Balance Sheets

    (Unaudited, Dollars in Thousands, Except per Share Amounts)

    -----------------------------------------------------------

                                                    December 31, September 30,

                                                         2009         2009

                                                         ----         ----

    ASSETS

    Current Assets:

      Cash and Cash Equivalents                         $38,619      $21,681

      Accounts Receivable, Net                           23,889       44,028

      Inventories                                        47,783       36,356

      Prepaid Expenses and Other Assets                   2,353        1,811

      Income Taxes Receivable                             2,439        2,148

      Deferred Income Taxes                               6,317        6,317

                                                          -----        -----

        Total Current Assets                            121,400      112,341

    Property, Plant and Equipment, Net                  112,634      114,645

    Intangible Assets, Net                                3,005        3,553

    Goodwill                                              3,088        3,144

    Deferred Income Taxes                                21,122       21,121

    Other Assets                                         10,150       10,037

                                                         ------       ------

        TOTAL ASSETS                                   $271,399     $264,841

                                                       ========     ========

    LIABILITIES AND SHAREHOLDERS' EQUITY

    Current Liabilities:

      Accounts Payable                                   $8,217       $7,444

      Accrued Liabilities                                 7,084        5,295

      Accrued Interest                                    4,125        1,650

      Employee Related Liabilities                        5,282        6,930

      Income Taxes Payable                                  201          189

      Deferred Revenues and Customer Deposits            11,101        6,911

      Current Portion of Environmental Remediation

       Reserves                                           2,110        2,522

      Current Portion of Long-Term Debt                     121          151

                                                            ---          ---

        Total Current Liabilities                        38,241       31,092

    Long-Term Debt                                      110,131      110,097

    Environmental Remediation Reserves                   23,898       24,168

    Pension Obligations                                  28,573       27,720

    Other Long-Term Liabilities                             628          667

                                                            ---          ---

        Total Liabilities                               201,471      193,744

                                                        -------      -------

    Commitments and Contingencies

    Shareholders' Equity

      Preferred Stock -$1.00 par value; 3,000,000

       authorized; none outstanding                           -            -

      Common Stock -$0.10 par value; 20,000,000 shares

       authorized, 7,540,591 and 7,504,591 issued           754          750

      Capital in Excess of Par Value                     72,664       72,322

      Retained Earnings                                   8,557        9,997

      Accumulated Other Comprehensive Loss              (12,047)     (11,972)

                                                        -------      -------

        Total Shareholders' Equity                       69,928       71,097

                                                         ------       ------

        TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY     $271,399     $264,841

                                                       ========     ========

 

    AMERICAN PACIFIC CORPORATION

    Condensed Consolidated Statements of Cash Flows

    (Unaudited, Dollars in Thousands)

    ---------------------------------

                                                          Three Months Ended

                                                             December 31,

                                                           2009         2008

                                                           ----         ----

    Cash Flows from Operating Activities:

      Net Income (Loss)                                  $(1,440)        $457

      Adjustments to Reconcile Net Income (Loss)

       to Net Cash Provided by Operating Activities:

          Depreciation and amortization                    4,053        3,969

          Non-cash interest expense                          159          159

          Share-based compensation                           346          132

          Excess tax benefit from stock option exercises       -           (3)

          Deferred income taxes                              (44)         (58)

          Loss on sale of assets                               5           53

          Changes in operating assets and liabilities:

            Accounts receivable, net                      20,141        6,661

            Inventories                                  (11,323)      (3,052)

            Prepaid expenses and other current assets       (540)         (12)

            Accounts payable                                 296       (2,627)

            Income taxes                                    (279)         325

            Accrued liabilities                            1,791          631

            Accrued interest                               2,475        2,509

            Employee related liabilities                  (1,643)      (2,739)

            Deferred revenues and customer deposits        4,208          415

            Environmental remediation reserves              (682)        (367)

            Pension obligations, net                         853          576

            Other                                           (269)         (79)

                                                            ----          ---

              Net Cash Provided by Operating Activities   18,107        6,950

                                                          ------        -----

    Cash Flows from Investing Activities:

      Capital expenditures                                (1,099)      (1,809)

      Acquisition of business, net of cash acquired            -       (6,653)

                                                             ---       ------

              Net Cash Used by Investing Activities       (1,099)      (8,462)

                                                          ------       ------

    Cash Flows from Financing Activities:

      Payments of long-term debt                             (59)        (108)

      Issuances of common stock, net                           -           32

      Excess tax benefit from stock option exercises           -            3

                                                             ---          ---

          Net Cash Used by Financing Activities              (59)         (73)

                                                             ---          ---

    Effect of Changes in Currency Exchange Rates on

     Cash                                                    (11)           -

                                                             ---          ---

    Net Change in Cash and Cash Equivalents               16,938       (1,585)

    Cash and Cash Equivalents, Beginning of Period        21,681       26,893

                                                          ------       ------

    Cash and Cash Equivalents, End of Period             $38,619      $25,308

                                                         =======      =======

 

    AMERICAN PACIFIC CORPORATION

    Supplemental Data

    (Unaudited, Dollars in Thousands)

    ---------------------------------

                                                        Three Months Ended

                                                           December 31,

                                                         2009         2008

                                                         ----         ----

    Operating Segment Data:

    Revenues:

      Fine Chemicals                                    $9,504      $20,384

      Specialty Chemicals                               12,803       17,359

      Aerospace Equipment                                8,325        5,756

      Other Businesses                                   3,432        2,130

                                                         -----        -----

        Total Revenues                                 $34,064      $45,629

                                                       =======      =======

    Segment Operating Income (Loss):

      Fine Chemicals                                     $(740)     $(1,024)

      Specialty Chemicals                                5,831        7,606

      Aerospace Equipment                                 (362)         410

      Other Businesses                                     (17)         545

                                                           ---          ---

        Total Segment Operating Income                   4,712        7,537

    Corporate Expenses                                  (4,573)      (4,112)

                                                        ------       ------

    Operating Income                                      $139       $3,425

                                                          ====       ======

    Depreciation and Amortization:

      Fine Chemicals                                    $3,328        3,208

      Specialty Chemicals                                  171          304

      Aerospace Equipment                                  423          331

      Other Businesses                                       4            3

      Corporate                                            127          123

                                                           ---          ---

        Total Depreciation and Amortization             $4,053       $3,969

                                                        ======       ======

    Segment EBITDA (a):

      Fine Chemicals                                    $2,588       $2,184

      Specialty Chemicals                                6,002        7,910

      Aerospace Equipment                                   61          741

      Other Businesses                                     (13)         548

                                                           ---          ---

        Total Segment EBITDA                             8,638       11,383

    Less: Corporate Expenses, Excluding Depreciation    (4,446)      (3,989)

    Plus: Share-based Compensation                         346          132

    Plus: Interest and Other Income, Net                    (8)          61

                                                           ---          ---

    Adjusted EBITDA (b)                                 $4,530       $7,587

                                                        ======       ======

    Reconciliation of Net Income (Loss) to

     Adjusted EBITDA (b):

    Net Income (Loss)                                  $(1,440)        $457

    Add Back:

      Income Tax Expense (Benefit)                      (1,120)         335

      Interest Expense                                   2,691        2,694

      Depreciation and Amortization                      4,053        3,969

      Share-based Compensation                             346          132

                                                           ---          ---

    Adjusted EBITDA                                     $4,530       $7,587

                                                        ======       ======

    (a)  Segment EBITDA is defined as segment operating income (loss) plus

         depreciation and amortization.

    (b)  Adjusted EBITDA is defined as net income (loss) before income tax

         expense (benefit), interest expense, depreciation and amortization,

         share-based compensation and environmental remediation charges (if

         any).

 

Segment EBITDA and Adjusted EBITDA are not financial measures calculated in accordance with GAAP and should not be considered as an alternative to income (loss) from operations as performance measures. Each EBITDA measure is presented solely as a supplemental disclosure because management believes that each is a useful performance measure that is widely used within the industries in which we operate. In addition, EBITDA measures are significant measurements for covenant compliance under our revolving credit facility. Each EBITDA measure is not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

SOURCE American Pacific Corporation